Chemotherapy Underused for Muscle-Invasive Bladder Cancer

A population-based study suggests a low use of perioperative chemotherapy for muscle-invasive bladder cancer, despite its association with a survival benefit

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.